Skip to main content

Glutaric Acidemia Type I: Diagnosis and Management

  • Chapter
  • First Online:
Nutrition Management of Inherited Metabolic Diseases
  • 966 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC. Glutaric aciduria; a “new” disorder of amino acid metabolism. Biochem Med. 1975;12(1):12–21.

    Article  CAS  Google Scholar 

  2. Kolker S, Garbade SF, Greenberg CR, Leonard JV, Saudubray JM, Ribes A, et al. Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res. 2006;59(6):840–7.

    Article  Google Scholar 

  3. Boy N, Muhlhausen C, Maier EM, Heringer J, Assmann B, Burgard P, et al. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis. 2017;40(1):75–101.

    Article  Google Scholar 

  4. Hoffmann GF, Athanassopoulos S, Burlina AB, Duran M, de Klerk JB, Lehnert W, et al. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics. 1996;27(3):115–23.

    Article  CAS  Google Scholar 

  5. Busquets C, Merinero B, Christensen E, Gelpi JL, Campistol J, Pineda M, et al. Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res. 2000;48(3):315–22.

    Article  CAS  Google Scholar 

  6. Boy N, Mengler K, Thimm E, Schiergens KA, Marquardt T, Weinhold N, et al. Newborn screening: a disease-changing intervention for glutaric aciduria type 1. Ann Neurol. 2018;83(5):970–9.

    Article  CAS  Google Scholar 

  7. Boy N, Garbade SF, Heringer J, Seitz A, Kolker S, Harting I. Patterns, evolution, and severity of striatal injury in insidious- versus acute-onset glutaric aciduria type 1. J Inherit Metab Dis. 2018. https://doi.org/10.1007/s10545-018-0187-y.

  8. Bjugstad KB, Goodman SI, Freed CR. Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1. J Pediatr. 2000;137(5):681–6.

    Article  CAS  Google Scholar 

  9. Kyllerman M, Skjeldal O, Christensen E, Hagberg G, Holme E, Lonnquist T, et al. Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1. Eur J Paediatr Neurol. 2004;8(3):121–9.

    Article  Google Scholar 

  10. Cerisola A, Campistol J, Perez-Duenas B, Poo P, Pineda M, Garcia-Cazorla A, et al. Seizures versus dystonia in encephalopathic crisis of glutaric aciduria type I. Pediatr Neurol. 2009;40(6):426–31.

    Article  Google Scholar 

  11. Gitiaux C, Roze E, Kinugawa K, Flamand-Rouviere C, Boddaert N, Apartis E, et al. Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients. Mov Disord. 2008;23(16):2392–7.

    Article  Google Scholar 

  12. Morris AA, Hoffmann GF, Naughten ER, Monavari AA, Collins JE, Leonard JV. Glutaric aciduria and suspected child abuse. Arch Dis Child. 1999;80(5):404–5.

    Article  CAS  Google Scholar 

  13. Bodamer O. Subdural hematomas and glutaric aciduria type I. Pediatrics. 2001;107(2):451.

    Article  CAS  Google Scholar 

  14. Vester ME, Bilo RA, Karst WA, Daams JG, Duijst WL, van Rijn RR. Subdural hematomas: glutaric aciduria type 1 or abusive head trauma? A systematic review. Forensic Sci Med Pathol. 2015;11(3):405–15.

    Article  Google Scholar 

  15. Harting I, Neumaier-Probst E, Seitz A, Maier EM, Assmann B, Baric I, et al. Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain. 2009;132(Pt 7):1764–82.

    Article  Google Scholar 

  16. Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet. 2003;121C(1):38–52.

    Article  Google Scholar 

  17. Heringer J, Boy SP, Ensenauer R, Assmann B, Zschocke J, Harting I, et al. Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol. 2010;68(5):743–52.

    Article  Google Scholar 

  18. Bahr O, Mader I, Zschocke J, Dichgans J, Schulz JB. Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. Neurology. 2002;59(11):1802–4.

    Article  CAS  Google Scholar 

  19. Pierson TM, Nezhad M, Tremblay MA, Lewis R, Wong D, Salamon N, et al. Adult-onset glutaric aciduria type I presenting with white matter abnormalities and subependymal nodules. Neurogenetics. 2015;16(4):325–8.

    Article  CAS  Google Scholar 

  20. Herskovitz M, Goldsher D, Sela BA, Mandel H. Subependymal mass lesions and peripheral polyneuropathy in adult-onset glutaric aciduria type I. Neurology. 2013;81(9):849–50.

    Article  Google Scholar 

  21. Korman SH, Jakobs C, Darmin PS, Gutman A, van der Knaap MS, Ben-Neriah Z, et al. Glutaric aciduria type 1: clinical, biochemical and molecular findings in patients from Israel. Eur J Paediatr Neurol. 2007;11(2):81–9.

    Article  Google Scholar 

  22. Serrano Russi A, Donoghue S, Boneh A, Manara R, Burlina AB, Burlina AP. Malignant brain tumors in patients with glutaric aciduria type I. Mol Genet Metab. 2018;125(3):276–80.

    Article  CAS  Google Scholar 

  23. Lenich AC, Goodman SI. The purification and characterization of glutaryl-coenzyme a dehydrogenase from porcine and human liver. J Biol Chem. 1986;261(9):4090–6.

    Article  CAS  Google Scholar 

  24. Strauss KA, Brumbaugh J, Duffy A, Wardley B, Robinson D, Hendrickson C, et al. Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx. Mol Genet Metab. 2011;104(1–2):93–106.

    Article  CAS  Google Scholar 

  25. Kolker S, Boy SP, Heringer J, Muller E, Maier EM, Ensenauer R, et al. Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - a decade of experience. Mol Genet Metab. 2012;107(1–2):72–80.

    Article  Google Scholar 

  26. Goodman SI, Kratz LE, DiGiulio KA, Biery BJ, Goodman KE, Isaya G, et al. Cloning of glutaryl-CoA dehydrogenase cDNA, and expression of wild type and mutant enzymes in Escherichia coli. Hum Mol Genet. 1995;4(9):1493–8.

    Article  CAS  Google Scholar 

  27. Goodman SI, Stein DE, Schlesinger S, Christensen E, Schwartz M, Greenberg CR, et al. Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations. Hum Mutat. 1998;12(3):141–4.

    Article  CAS  Google Scholar 

  28. Zschocke J, Quak E, Guldberg P, Hoffmann GF. Mutation analysis in glutaric aciduria type I. J Med Genet. 2000;37(3):177–81.

    Article  CAS  Google Scholar 

  29. Goodman SI, Woontner M. An explanation for metabolite excretion in high- and low-excretor patients with glutaric acidemia type 1. Mol Genet Metab. 2019;127(4):325–6.

    Article  CAS  Google Scholar 

  30. Schillaci LA, Greene CL, Strovel E, Rispoli-Joines J, Spector E, Woontner M, et al. The M405V allele of the glutaryl-CoA dehydrogenase gene is an important marker for glutaric aciduria type I (GA-I) low excretors. Mol Genet Metab. 2016;119(1–2):50–6.

    Article  CAS  Google Scholar 

  31. Christensen E, Ribes A, Merinero B, Zschocke J. Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2004;27(6):861–8.

    Article  CAS  Google Scholar 

  32. Greenberg CR, Prasad AN, Dilling LA, Thompson JR, Haworth JC, Martin B, et al. Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada. Mol Genet Metab. 2002;75(1):70–8.

    Article  CAS  Google Scholar 

  33. Naughten ER, Mayne PD, Monavari AA, Goodman SI, Sulaiman G, Croke DT. Glutaric aciduria type I: outcome in the Republic of Ireland. J Inherit Metab Dis. 2004;27(6):917–20.

    Article  CAS  Google Scholar 

  34. Boneh A, Beauchamp M, Humphrey M, Watkins J, Peters H, Yaplito-Lee J. Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. Mol Genet Metab. 2008;94(3):287–91.

    Article  CAS  Google Scholar 

  35. Hsieh CT, Hwu WL, Huang YT, Huang AC, Wang SF, Hu MH, et al. Early detection of glutaric aciduria type I by newborn screening in Taiwan. J Formos Med Assoc. 2008;107(2):139–44.

    Article  Google Scholar 

  36. Lindner M, Kolker S, Schulze A, Christensen E, Greenberg CR, Hoffmann GF. Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2004;27(6):851–9.

    Article  CAS  Google Scholar 

  37. Hennermann JB, Roloff S, Gellermann J, Gruters A, Klein J. False-positive newborn screening mimicking glutaric aciduria type I in infants with renal insufficiency. J Inherit Metab Dis. 2009;32(Suppl 1):S355–9.

    Article  Google Scholar 

  38. Moore T, Le A, Cowan TM. An improved LC-MS/MS method for the detection of classic and low excretor glutaric acidemia type 1. J Inherit Metab Dis. 2012;35(3):431–5.

    Article  CAS  Google Scholar 

  39. Muhlhausen C, Christensen E, Schwartz M, Muschol N, Ullrich K, Lukacs Z. Severe phenotype despite high residual glutaryl-CoA dehydrogenase activity: a novel mutation in a Turkish patient with glutaric aciduria type I. J Inherit Metab Dis. 2003;26(7):713–4.

    Article  CAS  Google Scholar 

  40. Kolker S, Greenberg CR, Lindner M, Muller E, Naughten ER, Hoffmann GF. Emergency treatment in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2004;27(6):893–902.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the late Distinguished Professor Stephen Goodman of the University of Colorado for his dedication to the diagnosis and treatment of GA-1 and his mentorship to many in the field of metabolism. We are also grateful to Daryl Goodman and Susana San Roman, as well as the members of the Goodman Biochemical Laboratory, for their previous retrospective analysis of metabolites in individuals with GA-1.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Curtis R. Coughlin II .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Coughlin, C.R. (2022). Glutaric Acidemia Type I: Diagnosis and Management. In: Bernstein, L.E., Rohr, F., van Calcar, S. (eds) Nutrition Management of Inherited Metabolic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-94510-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-94510-7_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-94509-1

  • Online ISBN: 978-3-030-94510-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics